ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Stock Holdings Lifted by Barclays PLC
Barclays PLC increased its position in shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) by 41.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 158,180 shares of the company’s stock after acquiring an additional 46,514 shares during the quarter. Barclays […]
Barclays PLC increased its position in shares of ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) by 41.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 158,180 shares of the company’s stock after acquiring an additional 46,514 shares during the quarter. Barclays […]
